Trump's threat of imposing a tariff on Denmark over desires to acquire Greenland has caught the attention of one of the ...

VANCOUVER, British Columbia and PERTH, Australia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- HIGHLIGHTS – FOURTH QUARTERThree new high ...

Novo Nordisk's CEO said on Wednesday side-effects were not a problem in the trial of its next-generation obesity drug ...

Shares of Google parent Alphabet slump after quarterly revenue misses analysts’ expectations, AMD’s data-center revenue ...

Novo Nordisk shares rose Wednesday after fourth-quarter earnings ... People taking Wegovy start off on the lowest dose – or the starter dose – then work their way up to stronger formulations so their ...

Novo Nordisk hopes the new treatment can build on the success of its flagship obesity drug, Wegovy. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this ...

Novo Nordisk scored a much-needed win on Friday, with early-stage data on a new weight-loss drug that suggested it could work better than the obesity blockbusters already on the market. Novo American ...

Jared Holz, Mizuho, joins 'Fast Money' to talk Novo Nordisk's recent climb ... Americans are ‘aching for retirement’ because their work is ‘bad and unfulfilling’ — 3 tips to turn ...

A small drug company's early-stage work has grabbed the interest of one of the world's largest pharmaceutical companies. A small drug company's early-stage work targeting sickle cell disease has ...

In March 2023, the NHS announced it would make Wegovy, a drug made by Danish firm Novo Nordisk, available on prescription ... How do they work? The jabs work by suppressing your appetite, making ...

Novo Nordisk has announced topline results from the phase 3b trial STEP UP, which investigated the effects of two doses of Wegovy (semaglutide) in over 1,400 patients over the course of 72 weeks. Both ...